Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential.
about
Depression and Obstructive Sleep Apnea (OSA)Control of sleep and wakefulnessUpdate of sleep alterations in depressionUnderstanding Phenotypes of Obstructive Sleep Apnea: Applications in Anesthesia, Surgery, and Perioperative MedicineThe impact of atypical antipsychotic use on obstructive sleep apnea: a pilot study and literature reviewEffects of intracerebroventricular injections of 5-HT on systemic vascular resistances of conscious rats.Tension-type headache associated with obstructive sleep apnea: a nationwide population-based studyRole of chemoreceptors in mediating dyspnea.Respiratory motor activity: influence of neuromodulators and implications for sleep disordered breathing.Obesity and obstructive sleep apnea-hypopnea syndrome.Using linkage analysis to identify quantitative trait loci for sleep apnea in relationship to body mass index.Trazodone increases arousal threshold in obstructive sleep apnoea.Optimal treatment of obstructive sleep apnea and excessive sleepiness.Serotonin transporter polymorphism is associated with increased apnea-hypopnea index in older adults.Sleep apnea in young abstinent recreational MDMA ("ecstasy") consumers.A systematic review and meta-analysis of the association between serotonergic gene polymorphisms and obstructive sleep apnea syndrome.Neural Control of the Upper Airway: Respiratory and State-Dependent Mechanisms.Chronic intermittent hypoxia affects endogenous serotonergic inputs and expression of synaptic proteins in rat hypoglossal nucleus.Pharmacotherapy of obstructive sleep apnea.Obstructive sleep apnea and severe mental illness: evolution and consequences.Pharmacologic therapy for sleep-related breathing disorders.Depression as a Manifestation of Obstructive Sleep Apnea.Self-reported obstructive sleep apnea is associated with nonresponse to antidepressant pharmacotherapy in late-life depression.Association between obstructive sleep apnea (OSA) and depression and the effect of continuous positive airway pressure (CPAP) treatment.Effect of sertraline on breathing in depressed patients without moderate-to-severe sleep-related breathing disorders.5-HTR2A and IL-6 polymorphisms and obstructive sleep apnea-hypopnea syndrome.Injection of L-glutamate into the insular cortex produces sleep apnea and serotonin reduction in rats.Polymorphisms of the 5-hydroxytryptamine 2A/2C receptor genes and 5-hydroxytryptamine transporter gene in Chinese patients with OSAHS.Long-term intermittent hypoxia: reduced excitatory hypoglossal nerve output.Superoxide scavengers improve rat pharyngeal dilator muscle performance.Association of serotonin transporter gene polymorphism with obstructive sleep apnea syndrome.Role of endogenous serotonin in modulating genioglossus muscle activity in awake and sleeping rats.Systems Biology Genetic Approach Identifies Serotonin Pathway as a Possible Target for Obstructive Sleep Apnea: Results from a Literature Search Review.Long-lasting bradypnea induced by repeated social defeat.Different polysomnographic patterns in military veterans with obstructive sleep apnea in those with and without post-traumatic stress disorder.Obstructive sleep apnea syndrome susceptible genes in the Chinese population: a meta-analysis of 21 case-control studies.The β2 -adrenoceptor agonist terbutaline recovers rat pharyngeal dilator muscle force decline during severe hypoxia.Time- and dose-related effects of three 5-HT receptor ligands on the genioglossus activity in anesthetized and conscious rats.Serotonin Reuptake Inhibitors in Obstructive Sleep Apnea: Associations in People with and without Epilepsy
P2860
Q21203932-BF898DFE-4C22-4044-9B29-F5B7A4692ED2Q24634619-DD91877B-C4D1-409D-9D9A-C86E31BD7FC8Q26781426-DB9A78B5-1B64-4651-A3E3-AEBE8BE4E1BDQ33679035-53206DAD-9460-420F-AF00-CF5A5BF3D0C2Q33924804-B3D6CFAA-CD75-4BBB-AC75-D63C629C6946Q34302242-E3FAC4BF-22B3-49A7-864D-D39935263710Q35533635-71CC26A3-DCC9-43DB-A685-24AC957B8B7AQ35800348-1B0AB6AF-2192-4E45-A3E0-7C6921ADD559Q36814787-76058EE2-0027-4140-BA5C-24BBF50DB0C5Q37118017-ADDB0774-287D-4BA7-AD93-454F5751B315Q37181834-9F6CE526-60FC-4766-9E41-983DC8CF1CBCQ37319348-6633F496-212E-4BDD-8284-A6F91CAB8127Q37428910-18176924-5087-4A38-81A6-D16B10954A6CQ37445743-A57DFE94-6F3B-48DF-AD83-E3B1E8747077Q37465039-022D0B93-1A49-4C98-A4D9-78AF187299C9Q37520757-01F1D58A-716C-46DA-9764-80F3AE182FA9Q37591858-69F1A27C-1D48-43DB-9B70-920646438011Q37685252-CAAC9144-E52E-4354-AC27-5975DC306DD9Q37994293-CC43C463-3605-4651-89E3-63C7BA9EC946Q38032813-5ACBD586-D75C-498F-BDCD-C6C61E299174Q38178318-A4BDA99F-FE86-49B9-84EF-667B4EEF2C5EQ38685274-7B2FEC5B-1E73-4D9A-8C4B-434650F6866FQ38820525-BD4C9483-C290-4348-8076-21E89034945EQ40324702-DFC3BB5F-B9CC-4A57-A286-D68ADB37E12CQ41251613-0348E577-F725-468F-AF60-664719830D32Q42177439-11716FBF-0A86-40E4-83CF-0BBDEB51688BQ43526243-C586DCB9-FB69-44CD-BCC3-A8782BA4EBADQ43977183-497F3D1F-40A2-443C-A9C1-33A1013A425BQ44960157-5ED4897F-19CE-4A11-BF83-DF545B1B6E6FQ45918482-7C994836-8036-4FE7-8C98-15F4B286246FQ46469288-48D70C10-B93C-4337-8EA7-50F589EC4513Q46601745-3AC7EF6C-4190-4733-BCA9-BC3EADDBC874Q47157280-D0992519-F1A7-4D8C-849E-E8AE0B5C089CQ47426638-92A66755-1AB2-4551-B954-0920471ABE8FQ47648815-102EE879-4BC9-4AC0-ABD0-E4A98FEF7B0FQ47977212-2FB5B136-331A-498A-AF65-ADC0972DB10BQ48113838-591E2101-5C0F-4568-8BC8-2F46A8B0511AQ48470699-96E2F16B-7A79-4344-AEDE-50D9A2A1C8F6Q58697569-F3215FEF-D8C9-4E67-949D-BD852847C618
P2860
Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential.
@ast
Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential.
@en
Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential.
@nl
type
label
Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential.
@ast
Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential.
@en
Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential.
@nl
prefLabel
Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential.
@ast
Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential.
@en
Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential.
@nl
P2860
P356
P1476
Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential.
@en
P2093
Sigrid C Veasey
P2860
P2888
P356
10.1007/BF03256636
P577
2003-01-01T00:00:00Z